The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Livac sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
Livac is a medical equipment company that develops and commercializes medical devices to reduce patient trauma resulting from surgical procedures. The company’s flagship product LiVac retractor is a disposable, pliable silicone device. It connects to controlled suction to generate a vacuum that brings together the liver and diaphragm. The company’s product finds application in laparoscopic procedures, primarily cholecystectomy, fundoplication, gastric banding, gastrectomy, gastroplasty, and other surgeries requiring liver retraction with a clear visual perspective for accessing the targeted organs. Livac is headquartered in Melbourne, Victoria, Australia.
The key metrics of Livac related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:
As Livac is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Livac.
For a detailed understanding of the performance of Livac, buy the report here.